Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ("Helix" or the "Company"), a clinical-stage...
TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ("Helix" or the "Company"), a clinical-stage...
Black Book Mid Year Update on Irish Health IT Adoption and Vendor Performance DUBLIN, IE / ACCESS Newswire / September...
HORGEN, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Numab Therapeutics AG (“Numab”), a biotechnology company advancing a proprietary pipeline of...
Phase 1 data for efarindodekin alfa (XTX301) demonstrate promising anti-tumor activity in patients with advanced solid tumors Achievement of milestone...
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular...
WALNUT CREEK, Calif., Sept. 8, 2025 /PRNewswire/ -- Vantiq, the leading global platform for building and operating intelligent systems in real-time,...
TransformativeMed Now Positioned as Go-To Platform for Intelligent Systems and AI leadership SEATTLE, Sept. 8, 2025 /PRNewswire/ -- TransformativeMed, the...
Increasing number of hospitals adopting AI-driven Quippe to improve clinical documentation and clinical decision support HERNDON, Va., Sept. 8, 2025...
Long-Term Data Adds to the Growing Body of Evidence Supporting the Compelling Clinical Profile of Pombiliti® + Opfolda®PRINCETON, N.J., Sept....
Data found 12 times higher risk of turnover among nonresponding clinicians, revealing how nonresponse bias distorts survey results and emphasizing...
ALK (ALKB:DC / OMX: ALK B) today announced that real-world evidence evaluating the clinical performance of the nasal adrenaline spray...
Company to present at session titled “Personalizing Sepsis Treatment” TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”...
Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out...
LEXINGTON, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
MELBOURNE, Australia and SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”),...
Study reveals how Cytovale's IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by...
Black Book Research pre-event survey reveals attendee priorities: smart hospitals, population health, and compliance-ready solutions DUBAI, UAE / ACCESS Newswire...
After decades of outreach and evidence—never refuted—it is urgent to fund two 3D-CBS devices that could halve cancer deaths, and...
DENVER, Sept. 4, 2025 /PRNewswire/ -- Residex® AI today announced that GenCare Lifestyle, a premier senior living provider with six...
MADISON, Wis. and BRADENTON, Fla., Sept. 4, 2025 /PRNewswire/ -- DeliverHealth, the leader in AI-powered clinical documentation, today announced that Coastal...